No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects-Reference-Cited by-同舟云学术

No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects

Published:2020-03 Issue: Volume:125 Page:170176
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Nauck M.A.^ORCID,Holle H.,Kahle M.,Tytko A.,Deacon C.F.,Holst J.J.^ORCID,Meier J.J.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference48 articles.

1. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions;Nauck;Lancet Diabetes Endocrinol.,2016

2. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations;Nauck;J. Clin. Endocrinol. Metab.,1993

3. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion;Salehi;J. Clin. Endocrinol. Metab.,2008

4. The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and Type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion;Jones;Diabetologia,1987

5. Effect of porcine gastric inhibitory polypeptide on ß-cell function in Type 1 and Type II diabetes mellitus;Krarup;Metab. Clin. Exp.,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of GIP Receptor in the CNS for the Pathogenesis of Obesity;Diabetes;2021-06-27

2. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms;Molecular Metabolism;2021-04

3. GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review;International Journal of Molecular Sciences;2020-02-22